Literature DB >> 26225178

Accuracy capabilities comparisons between Karakiewicz, Kattan and Cindolo nomograms in predicting outcomes for renal cancer carcinoma: A systematic review and meta-analysis.

Giorgio Ivan Russo1, Alessandro Di Rosa1, Vincenzo Favilla1, Eugenia Fragalà1, Tommaso Castelli1, Salvatore Privitera1, Sebastiano Cimino1, Giuseppe Morgia1.   

Abstract

INTRODUCTION: Several prognostic models have been proposed to predict outcomes of patients affected by renal cell carcinoma. We analyze the discriminative capabilities of Karakiewicz, Kattan and Cindolo nomograms and perform a meta-analysis to yield pooled area under the receiver operator curves (AUCs) for model comparison. The end points of interest were disease-recurrence free survival (DFS) and cancer-specific survival (CSS).
METHODS: An electronic search of the Medline and Embase was undertaken until July 2014. The AUC value, total number of patients, number of disease recurrence, and cancer-related deaths were extracted from the included references. AUCs of the models were converted to odds ratios (ORs). For the meta-analysis, ln(OR) was used for data pooling. For each nomogram, the combined OR was transformed back to a converted AUC (cAUC).
RESULTS: A total of 16 studies were identified including 26 710 patients. The derived comparison of cAUC values revealed better predictive capability of DFS for the postoperative Karakiewicz nomogram versus Kattan nomogram (p < 0.01), but not versus Cindolo (p = 0.432) and between Cindolo versus Kattan (p = 0.03). The Mantel-Haenszel derived comparison of cAUC values revealed better predictive capability for the preoperative Karakiewicz nomogram versus the Kattan nomogram (p < 0.01) and versus the Cindolo model (p < 0.01), but also between the postoperative Karakiewicz model versus the Kattan model (p < 0.01) and the Cindolo model (p < 0.01). The Kattan model showed better discriminative capability versus the Cindolo model (p < 0.01).
CONCLUSIONS: The predictive abilities of the pre- and postoperative Karakiewicz models are higher than Kattan or Cindolo in predicting DFS and CSS.

Entities:  

Year:  2015        PMID: 26225178      PMCID: PMC4479651          DOI: 10.5489/cuaj.2479

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  25 in total

1.  Decision curve analysis and external validation of the postoperative Karakiewicz nomogram for renal cell carcinoma based on a large single-center study cohort.

Authors:  Stefan Zastrow; Sabine Brookman-May; Thi Anh Phuong Cong; Stanislaw Jurk; Immanuel von Bar; Vladimir Novotny; Manfred Wirth
Journal:  World J Urol       Date:  2014-05-22       Impact factor: 4.226

2.  The Karakiewicz nomogram is the most useful clinical predictor for survival outcomes in patients with localized renal cell carcinoma.

Authors:  Min-Han Tan; Huihua Li; Caroline Victoria Choong; Kee Seng Chia; Chee Keong Toh; Tiffany Tang; Puay Hoon Tan; Chin Fong Wong; Weber Lau; Christopher Cheng
Journal:  Cancer       Date:  2011-05-12       Impact factor: 6.860

3.  Operating characteristics of a rank correlation test for publication bias.

Authors:  C B Begg; M Mazumdar
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

4.  Kattan postoperative nomogram for renal cell carcinoma: predictive accuracy in a Japanese population.

Authors:  Kazuya Suzuki; Tsutomu Nishiyama; Noboru Hara; Kohei Akazawa; Kota Takahashi
Journal:  Int J Urol       Date:  2011-01-12       Impact factor: 3.369

5.  Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis.

Authors:  John M Hollingsworth; David C Miller; Stephanie Daignault; Brent K Hollenbeck
Journal:  Cancer       Date:  2007-05-01       Impact factor: 6.860

Review 6.  EAU guidelines on renal cell carcinoma: 2014 update.

Authors:  Borje Ljungberg; Karim Bensalah; Steven Canfield; Saeed Dabestani; Fabian Hofmann; Milan Hora; Markus A Kuczyk; Thomas Lam; Lorenzo Marconi; Axel S Merseburger; Peter Mulders; Thomas Powles; Michael Staehler; Alessandro Volpe; Axel Bex
Journal:  Eur Urol       Date:  2015-01-21       Impact factor: 20.096

7.  Conditional survival predictions after nephrectomy for renal cell carcinoma.

Authors:  Pierre I Karakiewicz; Nazareno Suardi; Umberto Capitanio; Hendrik Isbarn; Claudio Jeldres; Paul Perrotte; Maxine Sun; Vincenzo Ficarra; Richard Zigeuner; Jacques Tostain; Arnaud Mejean; Luca Cindolo; Allan J Pantuck; Arie S Belldegrun; Laurent Zini; Alexandre de la Taille; Denis Chautard; Jean-Luc Descotes; Shahrokh F Shariat; Antoine Valeri; Peter F A Mulders; Hervé Lang; Eric Lechevallier; Jean-Jacques Patard
Journal:  J Urol       Date:  2009-10-17       Impact factor: 7.450

8.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

9.  Assessing the accuracy and generalizability of the preoperative and postoperative Karakiewicz nomograms for renal cell carcinoma: results from a multicentre European and US study.

Authors:  Luca Cindolo; Paolo Chiodini; Sabine Brookman-May; Ottavio De Cobelli; Matthias May; Stefano Squillacciotti; Cosimo De Nunzio; Andrea Tubaro; Ioan Coman; Bodgan Feciche; Michael Truss; Manfred P Wirth; Orietta Dalpiaz; Thomas F Chromecki; Shahrock F Shariat; Manuel Sanchez-Chapado; Maria del Carmen Santiago Martin; Bernardo Rocco; Luigi Salzano; Giuseppe Lotrecchiano; Francesco Berardinelli; Luigi Schips
Journal:  BJU Int       Date:  2013-03-07       Impact factor: 5.588

Review 10.  A review of integrated staging systems for renal cell carcinoma.

Authors:  Malek Meskawi; Maxine Sun; Quoc-Dien Trinh; Marco Bianchi; Jens Hansen; Zhe Tian; Michael Rink; Salima Ismail; Shahrokh F Shariat; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2012-05-03       Impact factor: 20.096

View more
  1 in total

1.  Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations.

Authors:  Brandon J Manley; Ed Reznik; Mazyar Ghanaat; Mahyar Kashan; Maria F Becerra; Jozefina Casuscelli; Daniel Tennenbaum; Almedina Redzematovic; Maria I Carlo; Yusuke Sato; Maria Arcila; Martin H Voss; Darren R Feldman; Robert J Motzer; Paul Russo; Jonathan Coleman; James J Hsieh; Ari A Hakimi
Journal:  Urol Oncol       Date:  2017-11-11       Impact factor: 3.498

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.